Background. We describe the hemodynamic response to initiation and withdrawal of inhaled
nitric oxide (NO) in infants with pulmonary hypertension after surgical repair of total …

Seventeen infants were treated with inhaled nitric oxide for critical pulmonary artery
hypertension after operations for congenital heart defects. In all 17 patients conventional …

Background. Inhaled nitric oxide selectively decreases pulmonary vascular resistance. This
study was performed to determine whether inhaled nitric oxide decreases the incidence of …

Objective: Inhaled nitric oxide therapy causes selective and sustained pulmonary
vasodilation in patients with pulmonary hypertension; however, attempts to discontinue …

BACKGROUND.: Endothelium-derived nitric oxide (NO) is a potent vasodilator and a major
mediator of pulmonary vascular tone. METHODS.: Five infants underwent a trial of inhaled …

OBJECTIVE--To assess the effect of inhaled nitric oxide (NO) on severe postoperative
pulmonary hypertension in children after surgical repair of a congenital heart defect …

Inhaled low-dose nitric oxide (2, 10, 20 ppm), together with high inspired oxygen
concentration (0.80), was administered after corrective operations 13 times to 10 infants …

We present the effects of abrupt discontinuation of inhaled nitric oxide (NO) in four patients
with severe hypoxemic respiratory failure. These patients ranged from 9 mo to 65 yr of age …

Objectives: Inhaled nitric oxide is a promising therapy to control pulmonary hypertension.
However, pulmonary hypertension caused by valvular heart disease is often refractory to …

The role of inhaled nitric oxide in the immediate postbypass period after surgical repair of
congenital heart disease is uncertain. In a controlled, randomized, double-blind study, we …